A pharmacoepidemiological study of Rivaroxaban use and potential adverse outcomes in routine clinical pratice in GermanyFirst published 01/10/2015 Last updated 23/04/2024 EU PAS number: EUPAS11145StudyFinalisedDownload as PDF
Leibniz Institute for Prevention Research and Epidemiology - BIPSGermany First published: 29/03/2010Last updated 26/02/2024 InstitutionNot-for-profitENCePP partner